Indication
Burns
33 clinical trials
52 products
2 drugs
Product
EHSG-KFClinical trial
A Phase IIb, Prospective, Intra-patient Randomised Controlled, Multicentre Study to Evaluate the Safety and Efficacy of an Autologous Bio-engineered Dermo-epidermal Skin Substitute (EHSG-KF) for the Treatment of Partial Deep Dermal and Full Thickness Burns in Adults and Adolescents in Comparison to Autologous Split-thickness Skin Grafts (STSG)Status: Active (not recruiting), Estimated PCD: 2022-11-30
Product
STSGClinical trial
An Observational Clinical Registry to Collect Safety and Efficacy Data on Wound Care in Medical CentersStatus: , Estimated PCD: 2028-12-31
Clinical trial
A Pilot Safety Study of Mesenchymal Stem Cell Derived Extracellular Vesicles for the Treatment of Burn Wounds.Status: Recruiting, Estimated PCD: 2024-06-01
Product
AGLE-102Clinical trial
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal BurnsStatus: Recruiting, Estimated PCD: 2024-12-22
Product
MW-IIIProduct
Silvadene CreamProduct
StrataGraftClinical trial
A Phase 3 Multicenter, Single-Arm, Open-Label Study Evaluating the Safety, Tolerability and Efficacy of StrataGraft® Construct in Pediatric Subjects With Deep Partial Thickness (DPT) Thermal BurnsStatus: Active (not recruiting), Estimated PCD: 2024-05-30
Clinical trial
Randomized Controlled Trial Assessing a Novel Glycopolymer Compound in the Treatment of Superficial Partial-Thickness BurnsStatus: Recruiting, Estimated PCD: 2024-03-01
Product
SilvadeneProduct
heparinClinical trial
Clinical Efficacy of Product Alimax ® (Sodic Heparin) in Treatment of Burns: Comparative Study of Raw Materials Between Two SuppliersStatus: Withdrawn, Estimated PCD: 2008-06-01
Product
Folder WaterClinical trial
A Multicenter, Multinational, Randomized, Controlled, Assessor Blinded Study, Performed in Subjects With Thermal Burns, to Evaluate the Efficacy and Safety of NexoBrid Compared to Gel Vehicle and Compared to Standard of CareStatus: Completed, Estimated PCD: 2018-06-12
Product
GelProduct
NexoBridClinical trial
A Phase IIb, Prospective, Intra-patient Randomised Controlled, Multicentre Study to Evaluate the Safety and Efficacy of an Autologous Bio-engineered Dermo-epidermal Skin Substitute (EHSG-KF) for the Treatment of Partial Deep Dermal and Full Thickness Burns in Children in Comparison to Autologous Split-thickness Skin Grafts (STSG)Status: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Prospective Study of Liposomal Bupivacaine for Pain Control of Split Thickness Skin Graft Donor SitesStatus: Recruiting, Estimated PCD: 2024-12-31
Product
LidocaineProduct
Liposomal bupivacaineProduct
BupivacaineClinical trial
A pRospective, Case-controlled Evaluation of oLIceridine for Moderate or sEVEre Pain in Patients With Acute Burn Injuries. (RELIEVE)Status: Completed, Estimated PCD: 2023-09-30
Product
OliceridineProduct
Historical opioid useClinical trial
The Effects of Metformin on Morbidity and Mortality in Elderly Patients- a Prospective Randomized Control Trial (RCT)Status: Not yet recruiting, Estimated PCD: 2028-03-01
Drug
MetforminProduct
PlacebosClinical trial
A Phase 1/Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of PMS-101 Administration in Patients With Burn(s)Status: Not yet recruiting, Estimated PCD: 2025-11-30
Product
PMS-101Clinical trial
Implementation of an Enteral Resuscitation Bundle for the Moderate-sized Burn at Kirtipur Hospital, NepalStatus: Recruiting, Estimated PCD: 2024-12-01
Product
Oral Rehydration SolutionProduct
Lactated RingerClinical trial
Phase 1 Study of Human Amnion Membrane Powder for Enhanced Wound HealingStatus: Completed, Estimated PCD: 2023-11-22
Product
Amnion MembraneClinical trial
Evaluation of Laser-assisted Drug Delivery of Bimatoprost for the Treatment of Hypertrophic Scar Hypopigmentation: A Within Patient-Controlled Trial in Skin of ColorStatus: Recruiting, Estimated PCD: 2024-12-30
Product
BimatoprostProduct
SalineClinical trial
Vitamin D Deficiency in Adults Following a Major Burn InjuryStatus: Recruiting, Estimated PCD: 2024-09-01
Product
ErgocalciferolClinical trial
A Between Patient, Pilot Randomized Controlled Study of Plurogel® Compared to Standard Topical Dressing in Burn InjuriesStatus: Recruiting, Estimated PCD: 2024-11-30
Product
PluroGelProduct
Standard dressingProduct
Pathogen-Reduced PlasmaProduct
Crystalloid SolutionsClinical trial
SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma.Status: Recruiting, Estimated PCD: 2028-01-01
Clinical trial
A Within Patient, Pilot Randomized Controlled Study of Plurogel® Compared to Standard Topical Dressing in Burn InjuriesStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Comparison of Fluid Resuscitation in Pediatric Burn Patients Using Crystalloids and With Albumin on Day Two.Status: Completed, Estimated PCD: 2022-12-18
Product
5% AlbuminProduct
Paeds SolutionClinical trial
The Effect of Tranexamic Acid (TXA) on Blood Loss in Burn Surgery - A Randomized, Double-Blinded Placebo-Controlled TrialStatus: Completed, Estimated PCD: 2021-11-02
Product
Tranexamic AcidDrug
VarlilumabClinical trial
Tranexamic Acid During Excisional Burn SurgeryStatus: Recruiting, Estimated PCD: 2025-01-01
Product
Tranexamic acidClinical trial
Oxycodone (10, 20 mg) in a Postoperative Dressing in Patients After Surgical Debridement of Burn Wounds. A Prospective, Double-blinded, Randomized, Controlled Trial.Status: Completed, Estimated PCD: 2018-02-28
Product
OxycodoneClinical trial
Efficacy of Tranexamic Acid in Debridement Surgery of Burns on the Volume of Bleeding in Transfusion Requirements at Centro Medico de Occidente'Status: Recruiting, Estimated PCD: 2022-01-01
Clinical trial
Assessment of Mechanisms of Improved Wound Healing of Anabolic Agents and Diet in Severely Burned PatientsStatus: Completed, Estimated PCD: 2011-04-01
Product
Insulin High DoseProduct
oxandroloneProduct
PropranololProduct
Growth HormoneProduct
InsulinProduct
IGF-1/IGFBP-3Product
ItraconazoleProduct
Growth Hormone + PropranololProduct
Oxandrolone and PropranololProduct
PlaceboClinical trial
Safety, Feasibility, and Acceptability of Patient-Controlled Anxiolysis With Dexmedetomidine (PCA-DEX) for Burn-care Dressing ChangesStatus: Completed, Estimated PCD: 2020-03-20
Product
DexmedetomidineClinical trial
Growth Hormone Therapy for Muscle Regeneration in Severely Burned PatientsStatus: Completed, Estimated PCD: 2021-11-02
Product
SomatropinProduct
0.09% Saline SolutionClinical trial
Evaluation of Liposomal Bipivicaine in Split Thickness Skin Graft Donor Sites in Burn PatientsStatus: Terminated, Estimated PCD: 2020-03-24
Product
ExparelClinical trial
A Pilot Randomized Controlled Crossover Trial of the Effectiveness of Disposable Nitrous Oxide Canisters in Providing Improved Pain Control During Burn Dressing Changes.Status: Recruiting, Estimated PCD: 2025-12-01
Product
Nitrous OxideClinical trial
A First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Examine the Safety, Tolerability, and Pharmacokinetics of cNP8 in Healthy AdultsStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Product
cNP8Clinical trial
INDICIA: Evolution of the Initial Distribution Volume of Glucose in the Severe Burned AdultsStatus: Not yet recruiting, Estimated PCD: 2026-11-05
Product
Glucose 30%